Global Allogeneic Cell Therapy Market Size-Forecasts to 2027
August 22, 2022 11:31 ET
|
Global Market Estimates
Brooklyn, New York, Aug. 22, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Allogeneic Cell Therapy Market is projected to grow...
GoodTime Ranks on the 2022 Inc. 5000 Annual List
August 16, 2022 17:43 ET
|
GoodTime
NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today GoodTime, the world’s first Meeting Optimization Engine that makes meetings smarter, made Inc. magazine’s prestigious Inc. 5000 list, ranking No....
Beam Benefits Recognized As One of Inc. 5000’s Fastest Growing Companies
August 16, 2022 13:23 ET
|
Beam Benefits
COLUMBUS, Ohio, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Beam Benefits, the digitally-native employee benefits company, today announced its ranking (No. 808) on the 2022 Inc. 5000, a list of the nation’s...
OJO Labs Named to Inc. Magazine’s List of Fastest-Growing Private Companies for Second Consecutive Year
August 16, 2022 08:46 ET
|
OJO Labs
AUSTIN, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today, Inc. revealed that OJO Labs, for the second year in a row, was named on its annual Inc. 5000 list at No. 355. The most prestigious ranking of...
Xevant Ranks No. 1 on the Inc. 5000 2022 List as the Fastest Growing Private Software Company in America
August 16, 2022 08:00 ET
|
Xevant, Inc.
LEHI, Utah, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today, Inc. revealed that Xevant is No. 28 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in...
Bellicum Reports Second Quarter 2022 Financial Results and Provides Operational Update
August 11, 2022 16:02 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial...
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 01, 2022 07:30 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, July 01, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced equity...
Bellicum Reports First Quarter 2022 Financial Results and Provides Operational Update
May 12, 2022 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial...
First Orion Named as an Inc. Magazine’s Best Workplaces for 2022
May 10, 2022 13:09 ET
|
First Orion Corp.
NORTH LITTLE ROCK, Ark. , May 10, 2022 (GLOBE NEWSWIRE) -- First Orion has been named to Inc. magazine’s annual Best Workplaces list. Featured in the May/June 2022 issue, hitting newsstands on May...
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2022 07:30 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, May 02, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced equity...